SUSQUEHANNA INTERNATIONAL GROUP, LLP - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 42 filers reported holding CATALYST BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$20,424
+5.5%
42,347
-23.1%
0.00%
Q2 2023$19,353
+60.5%
55,043
-5.5%
0.00%
Q1 2023$12,057
+68.5%
58,247
+331.5%
0.00%
Q4 2022$7,155
-28.4%
13,500
-31.1%
0.00%
Q3 2022$10,000
-94.1%
19,600
-79.5%
0.00%
Q2 2022$170,000
+466.7%
95,767
+114.1%
0.00%
Q1 2022$30,000
-60.5%
44,737
-45.3%
0.00%
Q4 2021$76,000
-90.6%
81,856
-58.6%
0.00%
Q3 2021$812,000
+164.5%
197,500
+178.9%
0.00%
Q2 2021$307,000
-59.6%
70,819
-53.0%
0.00%
Q1 2021$760,000
+112.3%
150,631
+165.4%
0.00%
Q4 2020$358,000
+645.8%
56,746
+406.7%
0.00%
Q3 2020$48,000
-91.8%
11,200
-88.7%
0.00%
Q2 2020$583,000
-7.0%
99,349
-30.8%
0.00%
Q1 2020$627,000
+60.8%
143,487
+150.4%
0.00%
Q4 2019$390,000
+193.2%
57,306
+110.9%
0.00%
Q3 2019$133,000
-92.1%
27,177
-88.2%
0.00%
Q2 2019$1,692,000
+100.0%
229,393
+119.9%
0.00%
Q1 2019$846,000
-15.3%
104,300
-17.6%
0.00%
Q4 2018$999,000
-71.0%
126,622
-60.3%
0.00%
-100.0%
Q3 2018$3,442,000
-32.2%
319,316
-26.6%
0.00%
-50.0%
Q2 2018$5,074,000
-40.5%
434,841
+31.5%
0.00%
-50.0%
Q1 2018$8,534,000
+3355.1%
330,781
+1162.5%
0.00%
Q1 2017$247,00026,2000.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders